• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性大麻素-CB2 受体轴在心肌病早期阶段保护缺血性心脏。

The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy.

机构信息

Department of Cardiac Surgery, University Clinical Centre Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Germany.

出版信息

Basic Res Cardiol. 2014 Jul;109(4):425. doi: 10.1007/s00395-014-0425-x. Epub 2014 Jul 1.

DOI:10.1007/s00395-014-0425-x
PMID:24980781
Abstract

Ischemic heart disease is associated with inflammation, interstitial fibrosis and ventricular dysfunction prior to the development of heart failure. Endocannabinoids and the cannabinoid receptor CB2 have been claimed to be involved, but their potential role in cardioprotection is not well understood. We therefore explored the role of the cannabinoid receptor CB2 during the initial phase of ischemic cardiomyopathy development prior to the onset of ventricular dysfunction or infarction. Wild type and CB2-deficient mice underwent daily brief, repetitive ischemia and reperfusion (I/R) episodes leading to ischemic cardiomyopathy. The relevance of the endocannabinoid-CB2 receptor axis was underscored by the finding that CB2 was upregulated in ischemic wild type cardiomyocytes and that anandamide level was transiently increased during I/R. CB2-deficient mice showed an increased rate of apoptosis, irreversible loss of cardiomyocytes and persistent left ventricular dysfunction 60 days after the injury, whereas wild type mice presented neither morphological nor functional defects. These defects were due to lack of cardiomyocyte protection mechanisms, as CB2-deficient hearts were in contrast to controls unable to induce switch in myosin heavy chain isoforms, antioxidative enzymes and chemokine CCL2 during repetitive I/R. In addition, a prolonged inflammatory response and adverse myocardial remodeling were found in CB2-deficient hearts because of postponed activation of the M2a macrophage subpopulation. Therefore, the endocannabinoid-CB2 receptor axis plays a key role in cardioprotection during the initial phase of ischemic cardiomyopathy development.

摘要

缺血性心脏病与炎症、间质纤维化和心室功能障碍有关,这些病变在心力衰竭发生之前就已经存在。内源性大麻素和大麻素受体 CB2 据称参与其中,但它们在心脏保护中的潜在作用尚不清楚。因此,我们在缺血性心肌病发展的初始阶段,即在心室功能障碍或梗塞发生之前,探讨了大麻素受体 CB2 的作用。野生型和 CB2 缺陷型小鼠每天接受短暂的、重复的缺血再灌注(I/R),导致缺血性心肌病。内源性大麻素-CB2 受体轴的相关性是由以下发现强调的:CB2 在缺血性野生型心肌细胞中上调,并且在 I/R 期间,花生四烯酸水平短暂增加。CB2 缺陷型小鼠的细胞凋亡率增加,心肌细胞不可逆丢失和左心室功能持续障碍 60 天后,而野生型小鼠既没有形态学也没有功能缺陷。这些缺陷是由于缺乏心肌细胞保护机制,因为 CB2 缺陷型心脏与对照相比,在重复 I/R 期间不能诱导肌球蛋白重链同工型、抗氧化酶和趋化因子 CCL2 的转换。此外,由于 M2a 巨噬细胞亚群的激活推迟,CB2 缺陷型心脏中发现了延长的炎症反应和不良的心肌重构。因此,内源性大麻素-CB2 受体轴在缺血性心肌病发展的初始阶段的心脏保护中发挥着关键作用。

相似文献

1
The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy.内源性大麻素-CB2 受体轴在心肌病早期阶段保护缺血性心脏。
Basic Res Cardiol. 2014 Jul;109(4):425. doi: 10.1007/s00395-014-0425-x. Epub 2014 Jul 1.
2
Impaired border zone formation and adverse remodeling after reperfused myocardial infarction in cannabinoid CB2 receptor deficient mice.大麻素CB2受体缺陷小鼠再灌注心肌梗死后边缘区形成受损及不良重塑
Life Sci. 2015 Oct 1;138:8-17. doi: 10.1016/j.lfs.2014.11.005. Epub 2014 Nov 14.
3
Myocardial maladaptation to pressure overload in CB2 receptor-deficient mice.心肌对 CB2 受体缺乏小鼠压力超负荷的适应性不良。
J Mol Cell Cardiol. 2019 Aug;133:86-98. doi: 10.1016/j.yjmcc.2019.06.003. Epub 2019 Jun 7.
4
Metallothioneins 1 and 2 Modulate Inflammation and Support Remodeling in Ischemic Cardiomyopathy in Mice.金属硫蛋白1和2调节小鼠缺血性心肌病中的炎症并支持重塑。
Mediators Inflamm. 2016;2016:7174127. doi: 10.1155/2016/7174127. Epub 2016 Jun 14.
5
Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice.脂肪酸酰胺水解酶缺乏与小鼠心肌缺血再灌注后的有害心脏效应有关。
Int J Mol Sci. 2022 Oct 21;23(20):12690. doi: 10.3390/ijms232012690.
6
CB2-deficiency is associated with a stronger hypertrophy and remodeling of the right ventricle in a murine model of left pulmonary artery occlusion.CB2 缺乏症与左肺动脉闭塞小鼠模型的右心室更强的肥大和重构有关。
Life Sci. 2018 Dec 15;215:96-105. doi: 10.1016/j.lfs.2018.11.003. Epub 2018 Nov 4.
7
The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy.2型大麻素受体可促进心肌细胞和成纤维细胞的存活,并预防缺血/再灌注诱导的心肌病。
FASEB J. 2009 Jul;23(7):2120-30. doi: 10.1096/fj.09-129478. Epub 2009 Feb 26.
8
2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction.2-花生四烯酸甘油可动员骨髓细胞,并在急性心肌梗死后恶化心脏功能。
Cardiovasc Res. 2019 Mar 1;115(3):602-613. doi: 10.1093/cvr/cvy242.
9
Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury.细胞外 RNA 和 TLR3-Trif 信号在心肌缺血再灌注损伤中的作用。
J Am Heart Assoc. 2014 Jan 3;3(1):e000683. doi: 10.1161/JAHA.113.000683.
10
Ablation Is Associated With Increased Nitro-Oxidative Stress During Ischemia-Reperfusion Injury: Implications for Human Ischemic Cardiomyopathy.消融与缺血再灌注损伤期间硝基氧化应激增加相关:对人类缺血性心肌病的影响。
Circ Heart Fail. 2017 Feb;10(2). doi: 10.1161/CIRCHEARTFAILURE.116.003523.

引用本文的文献

1
The endocannabinoid anandamide prevents TH17 programming of activated T lymphocytes while preserving TH1 responses.内源性大麻素花生四烯酸乙醇胺可防止活化的T淋巴细胞向TH17细胞分化,同时保留TH1反应。
Front Pharmacol. 2024 Dec 20;15:1528759. doi: 10.3389/fphar.2024.1528759. eCollection 2024.
2
Therapeutic potential of agents targeting cannabinoid type 2 receptors in organ fibrosis.靶向大麻素受体 2 的药物在器官纤维化中的治疗潜力。
Pharmacol Res Perspect. 2024 Dec;12(6):e1219. doi: 10.1002/prp2.1219.
3
Cannabinoids and triple-negative breast cancer treatment.
大麻素与三阴性乳腺癌的治疗。
Front Immunol. 2024 Aug 8;15:1386548. doi: 10.3389/fimmu.2024.1386548. eCollection 2024.
4
Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria.根据改善心脏保护疗法的临床前评估(IMPACT)标准,重新评估大麻素对缺血再灌注损伤的心脏保护作用。
Front Pharmacol. 2024 May 30;15:1382995. doi: 10.3389/fphar.2024.1382995. eCollection 2024.
5
CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies.CB2 大麻素受体作为心肌梗死的潜在靶点:分子发病机制与治疗策略的探索。
Int J Mol Sci. 2024 Jan 30;25(3):1683. doi: 10.3390/ijms25031683.
6
Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice.脂肪酸酰胺水解酶缺乏与小鼠心肌缺血再灌注后的有害心脏效应有关。
Int J Mol Sci. 2022 Oct 21;23(20):12690. doi: 10.3390/ijms232012690.
7
Macrophage, a potential targeted therapeutic immune cell for cardiomyopathy.巨噬细胞,一种用于心肌病的潜在靶向治疗免疫细胞。
Front Cell Dev Biol. 2022 Sep 30;10:908790. doi: 10.3389/fcell.2022.908790. eCollection 2022.
8
Expression and Functions of the CB Receptor in Human Leukocytes.CB受体在人白细胞中的表达及功能
Front Pharmacol. 2022 Feb 22;13:826400. doi: 10.3389/fphar.2022.826400. eCollection 2022.
9
Activation of the endocannabinoid system mediates cardiac hypertrophy induced by rosiglitazone.内源性大麻素系统的激活介导了罗格列酮诱导的心肌肥厚。
Acta Pharmacol Sin. 2022 Sep;43(9):2302-2312. doi: 10.1038/s41401-022-00858-x. Epub 2022 Feb 21.
10
M2b macrophages stimulate lymphangiogenesis to reduce myocardial fibrosis after myocardial ischaemia/reperfusion injury.M2b 巨噬细胞刺激淋巴管生成,以减少心肌缺血/再灌注损伤后的心肌纤维化。
Pharm Biol. 2022 Dec;60(1):384-393. doi: 10.1080/13880209.2022.2033798.